ASEAN Pressure Monitoring Devices Market Outlook (2022-2033)

ASEAN pressure monitoring devices market size is expected to reach US$ 536.0 million by 2033 from US$ 246.4 million in 2024. The market is estimated to record a CAGR of 9.0% from 2025 to 2033.

Executive Summary and ASEAN Pressure Monitoring Devices Market Analysis:

The pressure monitoring devices market in ASEAN is benefitting from substantial growth driven by rising prevalence of chronic diseases and continuous technological advancements, growing adoption of remote patient monitoring and telehealth solutions, and rising global healthcare expenditure and the increasing focus on preventive care. An estimated 37 million people in ASEAN are affected by CVD, making it the leading cause of death and morbidity, with a 148% increase in all cases from 1990 to 2021, CVD death rates were higher than the rest of the world in Laos, Indonesia, the Philippines, Vietnam, and Malaysia (Institute for Health Metrics and Evaluation, May, 2025).

Hypertension affects nearly 30% of adults in Asia, with Malaysia, Thailand, and Indonesia experiencing a significant burden. For instance, in Malaysia, a study on adolescents showed a hypertension prevalence of 24.5% in urban areas, while Indonesia's adolescents showed a 2.6% hypertension prevalence). The high prevalence of these conditions necessitates widespread use of blood pressure monitors, both in clinical settings and for home use, as well as more specialized devices for cardiac diagnostics.

ASEAN Pressure Monitoring Devices Market Segmentation Analysis: Key segments that contributed to the derivation of the pressure monitoring devices market analysis are product, application, and end user.

By product, pressure monitoring devices market is segmented into blood pressure monitors, pulmonary pressure monitors, intracranial pressure monitors, intraocular pressure monitors, accessories & consumables. The laparoscopes segment dominated the market in 2024. In terms of application, the market is segmented into respiratory disorders, glaucoma, cardiac disorders, neurological disorders, others. The cardiac disorders segment held the largest share of the market in 2024. By end user, the market is segmented into hospitals and clinics, home-care Settings, ambulatory surgical centers, others. Hospitals and clinics segment held the largest share of the market in 2024. ASEAN Pressure Monitoring Devices Market Outlook

An increasing number of countries in ASEAN now want to provide technology-enabled solutions to healthcare payers, providers and patients, helped in no small part by the expanding use of telemedicine and remote patient monitoring (RPM). Singapore, Indonesia, Thailand, Vietnam and Malaysia have increasingly realised that a strong Digital health ecosystem can facilitate the development and deployment of various digital health solutions--helped by healthtech start-ups, underlying technologies, and government initiatives, in order to leverage telemedicine and remote care. In Indonesia, devices for wearables have increased approximately 50% between 2020 and 2023 spurred by the government recommending the use of wearable health devices, National Health Insurance Scheme (JKN) supports recognised teleconsultations, and remote monitoring as an essential aspect of the individual health and wellbeing. Moreover, with the ongoing telemedicine expansion, we are now able to monitor chronic health conditions, such as hypertension consistently at home, when we were limited to consultations in-setting. Patients are now empowered monitor their hypertension at home and provider and patients have the opportunity of access to real-time data to retrospectively optimise treatment. While a large amount of the device components and finished high-end medical devices in Southeast Asia are being imported, Malaysia and Thailand are recognised as having the capabilities to manufacture medical devices and considered manufacturing and distribution hubs for high-quality medical devices within Southeast Asia and beyond; and are focusing investment on continuing to build local capacity, while both Indonesia and Vietnam appreciate the rising demand for domestic production, and are also building out their capabilities. This local production, coupled with the rising associated healthcare needs of an aging population, increasing healthcare spending across the region, demonstrates a promising opportunity for pressure monitoring devices in ASEAN medical markets.

ASEAN Pressure Monitoring Devices Market Country Insights

Based on region, the ASEAN pressure monitoring devices market is further segmented into Indonesia, Malaysia, Philippines, Singapore, Thailand, and Vietnam. The Indonesia held the largest share in 2024.

Indonesia represents the largest market for pressure monitoring devices in ASEAN. Indonesia's National Health Insurance (JKN) covers over 90% of the population as of March 2024, with the goal of universal coverage by the end of the year. There is significant investment in public and private hospitals. Malaysia's 2024 budget allocates MYR 4102 billion (USD 941 billion) for healthcare, creating opportunities for medical product development including patient monitoring. The Philippines is continuing with its Universal Health Care (LIHC) Act with 5.6% of its 2024 national budget going to health. Singapore emphasizes preventive care through initiatives like Healthier SG, which incentivizes individuals to manage their own health in a personalized way, with a supportive health spend. Thailand is already advancing its healthcare infrastructure with an eye to medical tourism, having 61 JCI-accredited medical facilities as of October 2023. Vietnam is also making strides in the health care space using AI and building on its telemedicine services, with a goal of being an ASEAN healthcare hub by 2030. These developments will inexorably lead to increased requirements for diagnostic and monitoring equipment, which includes pressure monitoring devices.

ASEAN Pressure Monitoring Devices Market Company Profiles

Medtronic Plc, GE HealthCare Technologies Inc, Koninklijke Philips NV, Omron Healthcare Inc, Baxter International Inc, Becton Dickinson and Co, Abbott Laboratories, Terumo Corp, Integra LifeSciences Holdings Corp, and Dragerwerkag & Co KGaA, are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers. Show more